ORCA Therapeutics Competitors and Similar CompaniesClear all

ORCA Therapeutics's competitors and similar companies include Clovis Oncology and Deciphera Pharmaceuticals.

	ORCA Therapeutics ORCA Therapeutics is a biopharmaceutical company designing and developing immunotherapies for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA).	Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Founding Date	Founding Date 2005	Founding Date 2009	Founding Date 2003
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations 's-Hertogenbosch, NL HQ Amsterdam, NL Nijmegen, NL	Locations Boulder, US HQ Paris, FR München, DE Dublin, IE Milano, IT Madrid, ES Zürich, CH see more	Locations Waltham, US HQ Lawrence, US
Employees	Employees 6	Employees 4843% increase	Employees 35037% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 10.6 m	Valuation ($) 2.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $148.8m (FY, 2021)	Revenue (est.) $163.4m (FY, 2023)
Net income	Net income N/A	Net income ($264.5m) (FY, 2021)	Net income ($194.9m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 1.7m	Total funding raised $ 357m	Total funding raised $ 714m